“Acquisitions are always an option”
Production at Fresenius Kabi The business of the group’s pharmaceutical division is expected to grow significantly. (Photo: Fresenius) Frankfurt The Fresenius healthcare group aims to play a key role in the multi-billion dollar biotechnology market. This was announced by the head of the Fresenius Kabi drug department, Michael Sen, in an interview with Handelsblatt. “Biopharmaceuticals … Read more